Phase 2 Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults aged 18 or older
- People who have been diagnosed with advanced breast cancer, confirmed through laboratory testing of tissue or cell samples
- People whose breast cancer has tested negative for HER2, and positive for hormone receptors (HR+), in either the original tumour or a secondary (metastatic) site
- People who have at least one tumour that can be measured using standard imaging guidelines (known as RECIST 1.1)
- People who have previously received between 2 and 4 lines of treatment, which must include at least one hormone therapy combined with CDK4/6 inhibitor drugs, and at least one chemotherapy treatment containing paclitaxel
- People who have previously received one line of a type of drug called an ADC (antibody-drug conjugate) as their first treatment
- People whose medical records include complete data on the key measures required for this study
- People with a physical fitness/performance score of 0 to 2 on a standard oncology scale (meaning able to carry out daily activities with no more than moderate limitation) (confirm with trial site)
- People with a life expectancy of more than 6 months
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- No exclusion criteria were listed in the provided text (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Primary endpoints
Progression-Free Survival (PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.